Drugs / DEP114
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07835074 | Jun 2027 → Dec 2028 expected | perennial allergic rhinitis | EMS | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06272409 | Feb → Mar 2025 overdue | allergic rhinitis | EMS | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DEP114 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06272409 ↗ |
| Route | Oral | “DEP114 oral solution” NCT06272409 ↗ |